跳至主要内容
临床试验/NCT04035902
NCT04035902Unknown4 期

Intraoperative IV Iron on the Postoperative Recovery of Red Blood Cell in Hip Arthroplasty Surgery

Konkuk University Medical Center0 个研究点目标入组 46 人开始时间: 2021年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
46
主要终点
postoperative hematocrit (%)

研究概览

简要总结

The objective of the present study is to determine the impact of intraoperative IV-iron supplementation on postoperative recovery of RBC mass by retrospectively analyzing and comparing the changes of postoperative hematocrit values after the surgery in patients underwent elective uni-limb total knee arthroplasty surgery with or without IV-iron supplementation during surgery

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

ferric carboxymaltose 1000 mg

Experimental

Ferric carboxymaltose is administered during surgery

干预措施: Ferric carboxymaltose (Drug)

control

Active Comparator

Ferric carboxymaltose is not administered

干预措施: control (Drug)

结局指标

主要结局

postoperative hematocrit (%)

时间窗: 7 days after surgery

hematocrit is evaluated on postoperative 7 days

次要结局

  • volume of post-operative bleeding (ml)(7 day)
  • intraoperative blood transfusion (ml)(1 day)
  • post-operative blood transfusion (ml)(7 days)
  • post-operative serum ferritin level (ng/ml)(1 day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tae-Yop Kim, MD PhD

Professor Anesthesiology

Konkuk University Medical Center

相似试验